Rezulin – Alliance for Human Research Protection

September 27, 2014

David Graham, MD

David Graham, MD, FDA’s Associate Director of Science and Medicine who, throughout his career, has been a

David Graham, MD

October 7, 2012

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

IV. What Do We Get for All That Money? According to the Kaiser Foundation:[1] The number of

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

September 15, 2012

US Healthcare Third Leading Cause of Death_Barbara Starfield, MD

Is US Healthcare Really the best in the World? Starfield_JAMA_2000 The findings by Barbara Starfield, MD, of

US Healthcare Third Leading Cause of Death_Barbara Starfield, MD

September 14, 2012

Safety Issues: FDA Scientists Collide with FDA Managers

EXAMPLES demonstrating a collision between FDA safety officers and FDA leadership: · In 1995, Dr. Leo

Safety Issues: FDA Scientists Collide with FDA Managers

September 8, 2012

FDA Scientists Collide with FDA Managers Re: Safety Issues

EXAMPLES demonstrating a collision between FDA safety officers and FDA leadership: In 1995, Dr. Leo Lutwak,

FDA Scientists Collide with FDA Managers Re: Safety Issues

August 20, 2012

Rx Drugs Recalled for Safety Issues from US market

FDA Drug Recall Due to Safety Issues 1980 – 2011 Drug Name: Approved Withdrawn Methaqualone

Rx Drugs Recalled for Safety Issues from US market

January 26, 2007

Bayer Settles Baycol AG Stuits $8 million

At least 100 people died because of the failure of Bayer to disclose thelethal risks of its

Bayer Settles Baycol AG Stuits $8 million

January 22, 2007

Role of Litigation in Defining Drug Risks_JAMA / BMJ

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Role of Litigation in Defining Drug Risks_JAMA / BMJ

October 26, 2006

Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP

Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP Sun, 23

Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP

October 26, 2006

Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT

Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT Mon, 26 Jul 2004 The

Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT

October 26, 2006

Congress & the White House must remedy a prescription for danger – LA Times / CBS News

October 26, 2006

Forbes: Face of The Year: David Graham

Forbes: Face of The Year: David Graham Mon, 13 Dec 2004 Forbes magazine has named Dr.

Forbes: Face of The Year: David Graham

October 26, 2006

FDA’s Double Standard Re: Advisory Committee Membership

FDA’s Double Standard Re: Advisory Committee Membership Mon, 15 Nov 2004 FDA’s inexplicable actions–the latest being the

FDA’s Double Standard Re: Advisory Committee Membership

October 26, 2006

FDA’s Lethal Weakness Requires More than Committees

FDA’s Lethal Weakness Requires More than Committees Sun, 7 Nov 2004 Bloomberg News reports that New York

FDA’s Lethal Weakness Requires More than Committees

Load More Articles

ALLIANCE FOR HUMAN RESEARCH PROTECTION

David Graham, MD

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

US Healthcare Third Leading Cause of Death_Barbara Starfield, MD

Safety Issues: FDA Scientists Collide with FDA Managers

FDA Scientists Collide with FDA Managers Re: Safety Issues

Rx Drugs Recalled for Safety Issues from US market

Bayer Settles Baycol AG Stuits $8 million

Role of Litigation in Defining Drug Risks_JAMA / BMJ

Cash Interests Taint Drug Advice – NATURE / Death a Risk of Antipsychotics – AP

Mosholder Suppressed Report Posted/ Bush Moves to Block Medical Suits – NYT

Congress & the White House must remedy a prescription for danger – LA Times / CBS News

Forbes: Face of The Year: David Graham

FDA’s Double Standard Re: Advisory Committee Membership

FDA’s Lethal Weakness Requires More than Committees

Subscribe to Our Newsletter!